Mutations in dynamin 2 cause dominant Centronuclear Myopathy

Archive ouverte

Bitoun, Marc | Maugenre, Svetlana | Jeannet, Pierre-Yves | Lacène, Emmanuelle | Ferrer, Xavier | Laforêt, Pascal | Martin, Jean-Jacques | Laporte, Jocelyn | Lochmuller, Hanns | Beggs, Alan, H. | Fardeau, Michel | Eymard, Bruno | Romero, Norma, Beatriz | Guicheney, Pascale

Edité par CCSD ; Nature Publishing Group -

International audience. Autosomal dominant centronuclear myopathy is a rare congenital myopathy characterized by delayed motor milestones and muscular weakness. In 11 families affected by centronuclear myopathy, we identified recurrent and de novo missense mutations in the gene dynamin 2 (DNM2, 19p13.2), which encodes a protein involved in endocytosis and membrane trafficking, actin assembly and centrosome cohesion. The transfected mutants showed reduced labeling in the centrosome, suggesting that DNM2 mutations might cause centronuclear myopathy by interfering with centrosome function.

Suggestions

Du même auteur

Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset

Archive ouverte | Bitoun, Marc | CCSD

International audience

Mutations in GFPT1-related congenital myasthenic syndromes are associated with synaptic morphological defects and underlie a tubular aggregate myopathy with synaptopathy

Archive ouverte | Bauché, Stéphanie | CCSD

International audience. Mutations in GFPT1 (glutamine-fructose-6-phosphate transaminase 1), a gene encoding an enzyme involved in glycosylation of ubiquitous proteins, cause a limb-girdle congenital myasthenic syndr...

A new Centronuclear Myopathy phenotype due to a novel Dynamin 2 mutation

Archive ouverte | Bitoun, Marc | CCSD

International audience

Chargement des enrichissements...